ClinicalTrials.gov
public full text
Public Domain
Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias
The investigation of biomarkers for immune status and metabolic state, as well as host microbiota composition, in patients with ventricular arrhythmias before and after radiofrequency ablation, can provide new insights for specific and personalized treatment. This can help establish early prediction and prognosis models and provide a basis for clinically effective diagnosis and treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Risk Stratification in Cardiovascular Medicine for Prognostic Assessment and Therapeutic Decision-Making: From Atrial Fibrillation to the Broader Disease Spectrum.#415375
- Analysis of Cardiac Biomarker Racial Discrepancies#1351454
- Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial#907441
- Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus#991667
- Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review.#469165
Record · ID 1294252
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive